KB Investment
VC Fund
Seoul, South Korea
KB Investment is a VC fund in Seoul focused on Software and Artificial Intelligence. Founded in 1990, KB Investment Co., Ltd. (KBIC) is one of Korea’s leading investment firms of venture capital and private equity funds with over USD 2.6 Billion of asset under management as of December 2023. KBIC is a subsidiary of KB Financial Group, Korea’s premier financial group with the largest domestic customer base as well as the widestnetwork of service branches in Korea.KBIC’s team is recognized for industry thought leadership, a broad network of powerful industry relationships, and a unique professional investment approach to investing. KBIC passionately support our portfolio companies with active guidance in all key aspects of team building, strategy, operations and governance
- Total investments:
- 439
- Last investment:
- Lead investor:
- 18%
Last updated:
For AI agents: llms.txt
Industries KB Investment invests in
Stages KB Investment invests in
Countries KB Investment invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 7 contacts → | |||
Round size
- Seed
- $737k–$7.2M
- Series A
- $2.5M–$36M
- Series B
- $5.2M–$44M
Investment Focus
Industry
- Software 55 (13%)
- Artificial Intelligence 54 (12%)
- Biotechnology 42 (10%)
- Information Technology 42 (10%)
- Health Care 37 (8%)
Stage
- Series A 136 (31%)
- Seed 102 (23%)
- Series B 102 (23%)
- Series C 23 (5%)
- Venture - Series Unknown 18 (4%)
Country
- South Korea 260 (59%)
- United States 32 (7%)
- Vietnam 6 (1%)
- Singapore 6 (1%)
- India 3 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Byong Ha Soh
Chief Executive Officer & Managing director
|
Chief Executive Officer & Managing director | Total investments: 0 | Find email | |
|
Jung Ho Yoo
Executive Managing Director
|
Executive Managing Director | Total investments: 2 | Find email | |
|
Kim Won-je
Head
|
Head | Total investments: 2 | Find email | |
|
Park Deok-gyu
Director
|
Director | Total investments: 1 | Find email | |
Seung-gon Hong
Team leader
|
Team leader | Total investments: 1 | Find email | |
| See all 7 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| GMI Cloud is a business of empowering the world's best ideas. Which provide businesses all over the globe with unmatched cloud access to top-tier GPUs like the NVIDIA H100 and streamlined software platform for integration, virtualization, and deployment. | $223M / Series B / Sep 30, 2026 | ||
| Nexcera provides innovative and sustainable medical solutions. | $16.2M / Series B / Sep 28, 2026 | ||
| TESOLLO develops robot and motion presenter products. | $3.4M / Series B / May 15, 2026 | ||
| Xpanner(Builtworlds Top 50), digital contech site solution, not only can bring productivity improvement(by 15% average), management efficency, safety and ESG improvement through our smart integration of conTech disparate products. | $18M / Series B / May 14, 2026 | ||
| Roai is a cutting-edge company that specializes in developing advanced autonomous manufacturing solutions powered by artificial intelligence and robotics. | $8.8M / Series A / Apr 30, 2026 | ||
| Robros is constantly creating technology to break through the barrier between people and robots in order to build a world in which everyone in the service industry can live a physically and emotionally happy life. | $6.8M / Venture - Series Unknown / Apr 27, 2026 | ||
| Medi Whale seeks to achieve sustainable healthcare where every eye can truly be the window to one’s health with our world's first-of-its-kind 1-stop AI screening platform solution for cardiovascular, renal, metabolic risk assessment, and eye disease diagnosis. Our AI Platform was developed through several clinical collaborations (Korea,Singapore, India, UK, and other European datasets) using structured longitudinal event-based datasets for the development of our retinal biomarker engines. RetiCVD® (cardiovascular disease risk assessment): Developed using coronary artery calcium (CAC) score, CAC is recognized as the gold standard for precise CVD risk calculation. Our CVD engine predicts the presence of CAC and provides a stratified probabilistic risk based on US ASCVD and EU SCORE guidelines.RetiCKD® (chronic kidney disease risk assessment): Developed using eGFR and full lab panel, our CKD engine has been demonstrated to achieve better predictive capability as compared to eGFR or full panel analysis.RetiEYE®: Referable Eye Disease engine detects and flags common aging-related eye modalities such as diabetic retinopathy, age-related macular degeneration, glaucoma, and cataract at its referable disease state.Medi Whale retinal-based systemic biomarkers have been clinically demonstrated to be non-inferior to current gold standards and are recognized by clinical and scientific communities with two Lancet Digital Health publications. | $13.3M / Series C / Mar 27, 2026 | ||
| Autonomous a2z is a driving mobility platform that provides autonomous driving service with judgement, control and recognition technologies. | $27.4M / Venture - Series Unknown / Mar 12, 2026 | ||
| BOS Semiconductors is a fabless semiconductor firm specializing in automotive-grade System-on-Chip (SoC) solutions and high-performance computing platforms. Its technologies support advanced driver assistance, autonomous driving, and centralized in-vehicle computing systems. | $60.3M / Series A / Feb 23, 2026 | ||
| As a fast-growing startup, Willog provides a “item-level condition monitoring” that innovates the supply chain of sensitive, perishable or valuable goods where condition monitoring is required, and its efforts are to create a transparent and connected logistics flow. Based on its patented sensor technology and its cloud-based software, Willog helpscompanies gain seamless visibility down to the item-level and control over their shipments across their supply chain so they can have condition foresights and insights to improve their bottom line.Willog acquired 25 enterprise customers including MNCs like Hyundai Motor Group and DHL Express since its establishment. Willog is rapidly expanding its presence in various industries including bio-pharmaceutical, fresh food, and special logistics, where condition monitoring is key to business continuity. Going forward, while strengthening its leadership position in Korea, Willog will accelerate global expansion with partnerships in America, Kazakhstan, and Malaysia. | Series B / Feb 03, 2026 | ||
| See all 439 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does KB Investment invest in?
KB Investment invests primarily in Software, Artificial Intelligence and Biotechnology startups, most often at Series A and Seed stage. Most of the 439 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is KB Investment's check size?
KB Investment typically joins rounds of $737k–$7.2M at Seed, $2.5M–$36M at Series A and $5.2M–$44M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds KB Investment participates in.
How do I contact KB Investment?
Public channels for KB Investment include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at KB Investment?
The team at KB Investment includes Byong Ha Soh (Chief Executive Officer & Managing director), Jung Ho Yoo (Executive Managing Director) and Kim Won-je (Head), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
